Vor Biopharma Inc. Quarterly Depreciation in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Vor Biopharma Inc. quarterly/annual Depreciation history and growth rate from Q1 2020 to Q2 2024.
  • Vor Biopharma Inc. Depreciation for the quarter ending June 30, 2024 was $900K, unchanged year-over-year.
  • Vor Biopharma Inc. Depreciation for the twelve months ending June 30, 2024 was $3.6M, a 11.2% increase year-over-year.
  • Vor Biopharma Inc. annual Depreciation for 2023 was $3.49M, a 38.3% increase from 2022.
  • Vor Biopharma Inc. annual Depreciation for 2022 was $2.53M, a 76.1% increase from 2021.
  • Vor Biopharma Inc. annual Depreciation for 2021 was $1.43M, a 137% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $3.6M $900K $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $3.6M $943K +$106K +12.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $3.49M $855K +$256K +42.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-20
Q3 2023 $3.24M $900K $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $3.24M $900K +$300K +50% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $2.94M $837K +$411K +96.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $2.53M $599K +$176K +41.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 $2.35M $900K +$600K +200% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $1.75M $600K +$200K +50% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $1.55M $426K +$115K +37% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $1.43M $423K +$184K +77% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 $1.25M $300K +$100K +50% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $1.15M $400K +$300K +300% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $850K $311K +$245K +371% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $605K $239K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 $200K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $100K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $66K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.